Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography
August 12th, 2022
The present protocol describes the concepts and technical application of the tensometric myograph technique using a multi-chamber myograph system in the experimental ex vivo assessment of mouse aortic endothelial function.
Overview
This protocol illustrates the application of the tensometric myograph technique for assessing mouse aortic endothelial function under controlled physiological conditions. The method is recognized for its reliability and reproducibility in studying vascular reactivity.
Key Study Components
Research Area
- Vascular biology
- Endothelial function assessment
- Microscopic analysis of blood vessels
Background
- The importance of endothelial function in vascular biology.
- The role of tensometric myography in vascular reactivity studies.
- Challenges in isolating and assessing particular layers of blood vessels.
Methods Used
- Tensometric myography as the primary technique
- Mouse aorta as the biological model
- Use of HEPES-PSS solution and high-potassium solution for experimentation
Main Results
- Demonstrated reproducibility of the measurements.
- Successful isolation and assessment of aortic segments' function.
- Enhanced understanding of acetylcholine-induced vasorelaxation dynamics.
Conclusions
- The study validates the tensometric myograph technique for endothelial function research.
- This method can significantly advance insights into vascular health and diseases.
Frequently Asked Questions
Executive Industry Relevance
Tensometric small volume chamber myography enables precise, reproducible measurement of endothelium-dependent vasorelaxation in isolated mouse aorta, supporting robust target validation in vascular biology. This platform provides controlled, near-physiological conditions for dissecting the functional contributions of vessel wall layers, directly informing early-stage cardiovascular drug discovery. Its quantitative outputs and standardization potential enhance predictive confidence at critical discovery inflection points.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous interrogation of endothelial and smooth muscle function in isolated vessel segments.
- Supports mechanistic de-risking by isolating layer-specific pharmacological responses.
- Facilitates functional target validation for vascular modulators and pathway effectors.
- Provides quantitative benchmarks for portfolio triage in cardiovascular programs.
Screening & Assay Development
- Delivers standardized, reproducible contractility and relaxation measurements for assay development.
- Prepares validated vessel segments for downstream pharmacological screening workflows.
- Enables quantitative assessment of dose-response to agonists and inhibitors.
- Supports assay scalability and platform reuse across vessel types and conditions.
Translational & Preclinical Research
- Aligns ex vivo vascular reactivity data with disease-relevant mechanisms in preclinical models.
- Provides continuity from discovery through preclinical validation of endothelial function.
- Enables risk-adjusted advancement decisions based on functional biomarker outputs.
- Supports translational biomarker alignment for vascular health and dysfunction.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies with translational vascular research.
- Discovery Biology: Supports hypothesis testing on endothelial and smooth muscle contributions to vascular tone.
- Screening: Provides reproducible, quantitative readouts for compound evaluation and assay standardization.
- Analytics: Enables force normalization and statistical comparison of pharmacological effects across conditions.
- Translational Research: Connects ex vivo functional data to in vivo vascular health and disease models.
- Enterprise Reuse: Offers a reusable platform for diverse vessel types and pharmacological challenges.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular target validation.
- Operational Value: Delivers standardized, reproducible, and scalable measurements for cross-study comparability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by de-risking early-stage programs.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of vascular drug candidates.
Implementation Considerations
- Requires expertise in vascular dissection and myograph operation.
- Needs access to tensometric myograph instrumentation and data acquisition systems.
- Demands rigorous cross-team standardization of protocols and data normalization.
- Adaptable to various vessel types but sensitive to tissue handling and preparation quality.
- Limited throughput compared to some automated platforms; best suited for mechanistic and validation studies.
Biopharma FAQs
Chapters in this video
0:05
Introduction
0:56
Myograph Unit Preparation
2:03
Isolation and Mounting of the Aortic Segments onto the Myograph Chamber
3:24
Measurement of Endothelium-Dependent Vasorelaxation in Aortic Rings
5:18
Effects of General Inhibitors of NO Production on Endothelium-Mediated Vasorelaxation
6:25
Contribution of the Endothelial Layer to Aortic Vasorelaxation
8:00
Results: Mechanisms Underlying Endothelial-Dependent Vasorelaxation Using Tensometric Small Volume Chamber Myography in a Murine Model
9:06
Conclusion
